Paper26475367
Hypereosinophilic Syndrome.
Curtis C and 1 other. Clin Rev Allergy Immunol, 2016. Cited by 138 papers, by iCite.
Cite this record
ConductScience Library. Hypereosinophilic Syndrome. Papers, record 26475367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26475367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypereosinophilic Syndrome | Major topic |
| Combined Modality Therapy | |
| Diagnosis, Differential | |
| Disease Management | |
| Humans | |
| Treatment Outcome |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12660384 | A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12660384 | PubMed |
| 2 | 18344568 | Treatment of patients with the hypereosinophilic syndrome with mepolizumab. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18344568 | PubMed |
| 3 | 24407160 | Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA. | Exp Hematol | 2014 | https://conductscience.org/library/papers/24407160 | PubMed |
| 4 | 20639008 | Refining the definition of hypereosinophilic syndrome. | J Allergy Clin Immunol | 2010 | https://conductscience.org/library/papers/20639008 | PubMed |
| 5 | 21761433 | World Health Organization-defined eosinophilic disorders: 2011 update on diagnosis, risk stratification, and management. | Am J Hematol | 2011 | https://conductscience.org/library/papers/21761433 | PubMed |
| 6 | 17868859 | Cardiovascular manifestations of hypereosinophilic syndromes. | Immunol Allergy Clin North Am | 2007 | https://conductscience.org/library/papers/17868859 | PubMed |
| 7 | 2088325 | Interferon-alpha for the hypereosinophilic syndrome. | Ann Intern Med | 1990 | https://conductscience.org/library/papers/2088325 | PubMed |
| 8 | 16406016 | FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. | Leuk Res | 2006 | https://conductscience.org/library/papers/16406016 | PubMed |
| 9 | 19630574 | Hypereosinophilic syndrome: current approach to diagnosis and treatment. | Annu Rev Med | 2009 | https://conductscience.org/library/papers/19630574 | PubMed |
| 10 | 17868858 | Gastrointestinal eosinophilia. | Immunol Allergy Clin North Am | 2007 | https://conductscience.org/library/papers/17868858 | PubMed |
| 11 | 17868860 | Pulmonary eosinophilic syndromes. | Immunol Allergy Clin North Am | 2007 | https://conductscience.org/library/papers/17868860 | PubMed |
| 12 | 18004179 | Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics. | Medicine (Baltimore) | 2007 | https://conductscience.org/library/papers/18004179 | PubMed |
| 13 | 497706 | Strongyloides stercoralis infection in former Far East prisoners of war. | Br Med J | 1979 | https://conductscience.org/library/papers/497706 | PubMed |
| 14 | 17868857 | Dermatologic manifestations of the hypereosinophilic syndromes. | Immunol Allergy Clin North Am | 2007 | https://conductscience.org/library/papers/17868857 | PubMed |
| 15 | 9758611 | Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. | Am J Hum Genet | 1998 | https://conductscience.org/library/papers/9758611 | PubMed |
| 16 | 23040887 | Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. | J Allergy Clin Immunol | 2013 | https://conductscience.org/library/papers/23040887 | PubMed |
| 17 | 22935585 | Novel targeted therapies for eosinophilic disorders. | J Allergy Clin Immunol | 2012 | https://conductscience.org/library/papers/22935585 | PubMed |
| 18 | 17868856 | Lymphocytic variant hypereosinophilic syndromes. | Immunol Allergy Clin North Am | 2007 | https://conductscience.org/library/papers/17868856 | PubMed |
| 19 | 18664881 | Eosinophilic gastrointestinal diseases (EGIDs). | J Pediatr Gastroenterol Nutr | 2008 | https://conductscience.org/library/papers/18664881 | PubMed |
| 20 | 14726461 | Strongyloides stercoralis in the Immunocompromised Population. | Clin Microbiol Rev | 2004 | https://conductscience.org/library/papers/14726461 | PubMed |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 138 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42927137 | A Case of Idiopathic Hypereosinophilic Syndrome With High WT1 (Wilms' Tumor Gene) mRNA. | Cureus | 2026 | https://conductscience.org/library/papers/42927137 | PubMed |
| 42824263 | A Retrospective Review of 1821 Cases of Eosinophilia in a Single-Center Study in Eastern China. | EJHaem | 2026 | https://conductscience.org/library/papers/42824263 | PubMed |
| 42688267 | Hypereosinophilic syndrome with Löffler endocarditis and multiple cerebral infarctions in a patient with a CLL-phenotype clonal B-cell population: a case report. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42688267 | PubMed |
| 42657158 | Mepolizumab reduces systemic corticosteroid-related toxicities and healthcare burden in patients with eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome: a retrospective database study. | Front Allergy | 2026 | https://conductscience.org/library/papers/42657158 | PubMed |
| 42513483 | Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort. | J Clin Med | 2026 | https://conductscience.org/library/papers/42513483 | PubMed |
| 42014519 | Al18F-FAPI PET/CT in hypereosinophilic syndrome with cardiac involvement and its potential association with eosinophil extracellular traps. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42014519 | PubMed |
| 41833286 | Redefining Hematology Referral Thresholds for Eosinophilia. | Eur J Haematol | 2026 | https://conductscience.org/library/papers/41833286 | PubMed |
| 41567200 | From hypereosinophilia to hypereosinophilic syndrome: real-world application of a two-tailed approach for HES diagnosis. | Front Immunol | 2025 | https://conductscience.org/library/papers/41567200 | PubMed |
| 41415327 | Refractory erythroderma in idiopathic hypereosinophilic syndrome: A case treated with mepolizumab and abrocitinib. | SAGE Open Med Case Rep | 2025 | https://conductscience.org/library/papers/41415327 | PubMed |
| 41322417 | Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence. | Front Immunol | 2025 | https://conductscience.org/library/papers/41322417 | PubMed |
| 41209273 | Idiopathic hypereosinophilic syndrome complicated by computed tomography-negative cerebral infarction, strangulated intestinal obstruction, and hepatic portal venous gas: a case report of multi-system involvement. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/41209273 | PubMed |
| 40943043 | Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40943043 | PubMed |
| 40656763 | Burden of hypereosinophilic syndromes in the United States: Patients' perspective. | J Allergy Clin Immunol Glob | 2025 | https://conductscience.org/library/papers/40656763 | PubMed |
| 40630493 | Primary care physicians play a crucial role in diagnosing and managing rare eosinophilic diseases: HES and EGPA. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40630493 | PubMed |
| 40486501 | Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes. | Front Allergy | 2025 | https://conductscience.org/library/papers/40486501 | PubMed |
| 40418815 | Tracking Public Interest in Rare Diseases and Eosinophilic Disorders in Germany: Web Search Analysis. | JMIR Infodemiology | 2025 | https://conductscience.org/library/papers/40418815 | PubMed |
| 40396537 | Hypereosinophilia: clinical and therapeutic approach in 2025. | Curr Opin Allergy Clin Immunol | 2025 | https://conductscience.org/library/papers/40396537 | PubMed |
| 40382631 | Benralizumab for acute thromboembolism in hypereosinophilic syndrome: a case report. | Allergy Asthma Clin Immunol | 2025 | https://conductscience.org/library/papers/40382631 | PubMed |
| 40297299 | Eosinophilic Granulomatous Polyangiitis with Autoimmune Hemolytic Anemia: A Case Report and Review of the Literature. | J Asthma Allergy | 2025 | https://conductscience.org/library/papers/40297299 | PubMed |
| 40283978 | Biologic Agents in Idiopathic Hypereosinophilic Syndrome. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283978 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26475367
GET https://conductscience.org/api/papers/v1/26475367/references?page=2